A molecular epidemiological analysis was performed to reveal the clonal association of Staphylococcus aureus strains isolated from patients with bullous impetigo. Pulsed-field gel electrophoresis with cluster analysis, genetic and phenotypic characterizations, and antimicrobial susceptibility profiling of 88 S. aureus strains isolated from outpatients at 4 hospitals in the Kansai district in Japan were undertaken. Three distinct clonal groups were identified: 2 of them carried the exfoliative toxin (ET) A gene (eta), and the other carried the ETB gene (etb). The former groups represent 2 eta-positive clonal groups that have not been described previously. All the strains in the more dominant eta-positive clonal group and some of the strains in the etb-positive clonal group were methicillin-resistant S. aureus (MRSA) showing borderline-to-moderate resistance to b-lactams. These MRSA strains appear to be emerging clonal groups that have not been considered in previous epidemiological studies of ET-producing S. aureus in Japan and thus pose a significant threat for future treatment of patients with bullous impetigo and/or staphylococcal scaldedskin syndrome.
Staphylococcal scalded-skin syndrome (SSSS), or Ritter Disease, is a blistering skin disease caused by Staphylococcus aureus [1] . It is a disease primarily of young children and neonates. The localized form of SSSS is known as bullous impetigo, which is seen frequently at the site of infection, especially in the extremities, in older children. Severe cases are often observed in neonates as widespread blistering on the entire body surface. The blister formation on the skin, the main symptom of SSSS, is caused by exfoliative toxins (ETs) produced by S. aureus [1] [2] [3] . Serologically, ETs involved in human diseases consist of 2 types, ETA and ETB [4] . Both toxins cause exfoliation of the epidermis without necrolysis or inflammatory response of the skin [1] . The molecular mechanism of the action of ETs has long been a mystery, but it was demonstrated recently that ETA is a serine protease that specifically cleaves desmoglein 1, a desmosomal protein connecting epidermal cells predominant in the granular layer of epidermis [5] . Epidemiological studies revealed that a small number of clinically isolated S. aureus strains possess genes for ETs [1] , which suggests that these genes were acquired through horizontal transfer during the evolution of S. aureus. Indeed eta, the gene for ETA, has been shown to be encoded on the genome of a temperate phage (fETA) [6] , and etb, the gene for ETB, is encoded on large plasmids [7, 8] ; however, fine molecular epidemiological studies looking at the clonality of S. aureus strains isolated from skin infection have not been performed. We therefore collected S. aureus strains from outpatients with bullous impetigo at 4 hospitals in Kansai District in Japan and examined their clonal association by analyzing genomic DNA profiles, genetic and phenotypic characteristics, and antibiotic susceptibilities.
Materials and Methods
Bacterial strains. Eighty-eight S. aureus clinical isolates were collected between June and September 1999. They were isolated from skin swabs taken from outpatients with bullous impetigo. There were no duplicate strains from the same patient. Strains were collected from 4 hospitals located in the Kansai area and were identified as S. aureus by their ability to produce coagulase and clumping factor. S. aureus was grown aerobically in heart infusion broth (Difco) at 37 C, unless otherwise noted. DNA manipulation. Routine DNA manipulations were performed by standard procedures [9] . Chromosomal DNA from staphylococcal cells was prepared as described elsewhere [6] . Financial support: Grant-in-Aid for Scientific Research on Priority Areas (C 13226080) from the Ministry of Education, Science, Sports, and Culture of Japan.
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Polymerase chain reaction (PCR). PCR primers used in this study are listed in table 1. PCR products were analyzed by electrophoresis on 1% agarose gels, purified using a GENECLEAN kit (Qbiogene), and sequenced to ensure that the appropriate portions were amplified. The purified PCR products were labeled with peroxidase, using a 3 0 oligolabeling kit (Amersham) for hybridization. Pulse-field gel electrophoresis (PFGE) and genetic and phenotypic characterizations. PFGE analysis of Sma I-digested chromosomal DNA was performed according to standard protocols, using a contour-clamped homogeneous electric field DR-II apparatus (BioRad) [6] . The gels were stained with ethidium bromide and photographed. The data were converted to PICT files and entered into the GelComparII program (Applied Maths) to generate a dendrogram based on the Dice coefficient, using the unweighted pair group method [10] with 1% position tolerance. Together, the genetic profiles of various toxin genes and a gene for penicillin-binding protein 2' (mecA) in these strains were investigated by Southern blot hybridization after PFGE. The investigated toxin genes included genes for ET (eta and etb), enterotoxin (sea, seb, sec, sed, and seg), toxic shock syndrome toxin 1 (TSST-1; tst-1 ), and epidermal NOTE. edinA, edinB, and edinC, epidermal cell differentiation inhibitor genes; eta and etb, exfoliative toxin genes; int, integrase of temperate phage of exfoliative toxin gene; mecA, penicillin-binding protein 2' gene; sea, seb, sec, sed, and seg, enterotoxin genes; tst-1, toxic shock syndrome toxin-1 gene.
a Polymerase chain reaction amplification protocols were as follows: initial denaturation step at 94 C for 2 min, followed by 25 cycles of 94 C for 15 s of denaturation, different annealing temperatures depending on primer sequences for 30 s, and 72 C for 1 min. Primers for sea-sed, seg, edinA-edinC, tst-1, int, and mecA were designed according to the nucleotide sequences deposited in GenBank (accession nos.: sea, M18970; seb, M11118; sec, X05815; sed, M94872; seg, AF064773; edinA, M63917; edinB, AJ277173; edinC, AP003088; tst-1, U93688; int, AP001553; and mecA, Y00688). cell differentiation inhibitor (EDIN; edinA, edinB, and edinC ). In separate experiments, coagulase serotyping and the production of enterotoxin and TSST-1 were investigated using coagulase typespecific antiserum (Denka-Seiken), an enterotoxin detection kit (SET-RPLA; Denka Seiken), and a TSST-1 detection kit (TST-RPLA; Denka Seiken), respectively.
Results
Genomic profiling and genetic and phenotypic characterizations. The results of PFGE with cluster analysis and genetic and phenotypic characterizations of 88 S. aureus strains isolated from outpatients at 4 hospitals in the Kansai district in Japan are summarized in figure 1 . Of the 88 isolates, 42 (47.7%) were eta positive, and 10 (11.4%) were etb positive. In total, 52 strains (59.1%) were positive for an ET gene, and there were no strains possessing both eta and etb. This ratio was slightly lower than that obtained in Great Britain and Ireland, where 81 (69.8%) of 116 strains from patients with SSSS were positive for ET production [11] . On the other hand, 24 strains were positive for at least 1 enterotoxin gene or the tst-1 gene (27.3%). Several strains were positive for . 1 enterotoxin gene, and all tst-1-positive strains were positive for sec. Two strains were positive for edinA (2.3%), 1 was positive for edinB (1.1%), and 10 were positive for edinC (11.4%). All etb-positive strains were positive for edinC, which is consistent with our recent finding that edinC and etb are colocated on the ETB plasmid [8] . We also noted that 1 of the 2 edinApositive strains was positive for eta. A surprising finding was that, among the 88 strains, 45 (51.1%) were positive for mecA.
PFGE analysis separated the 88 isolates into 4 clusters-23 isolates in cluster I, 10 isolates in cluster II, 32 isolates in cluster III, and 23 isolates in cluster IV (figure 1). Comparison of DNA profiles and genetic and phenotypic characterizations of the isolates provided further insights. The eta-positive strains were found in 3 clusters, with clusters III and IV as the major clusters and cluster I as the minor cluster. In cluster III, 4 strains were categorized into subcluster IIIa, and 28 were categorized into subcluster IIIb. Two strains in subcluster IIIa and all 28 strains in subcluster IIIb were eta positive; eta genes are located on 490-kb DNA fragments in the strains of subcluster IIIa and on 400-kb DNA fragments in the strains of subcluster IIIb. The subcluster IIIa strains were coagulase nontypeable (NT), and the subcluster IIIb strains were coagulase type III. Furthermore, 27 of the subcluster IIIb strains were mecA positive, and the mecA probe hybridized to DNA fragments with very similar sizes (180-190 kb). In cluster IV, 9 eta-positive strains formed a subcluster. All these strains were coagulase NT, and their eta genes were located on 490-kb DNA fragments. Cluster I contained 3 eta-positive strains: 1 was coagulase NT (strain 1), and 2 were type V (strains 4 and 5). eta-Positive strains in clusters IV and I were mecA negative. In all eta-positive strains, except for strains 4 and 5, the probe for fETA integrase (int) hybridized to the eta-containing DNA fragments. Furthermore, in the PCR using primers designed to amplify the int-left attachment site and eta-right attachment site regions of fETA lysogens, these eta-positive, int-positive strains yielded PCR products that were the same size as those from fETA lysogens [6] . These results imply that the eta genes in these clinical isolates reside on the prophage genomes integrated at the same att B site as that for fETA, with a few exceptions. In addition, the 10 etb-positive strains were all identified in cluster I; 9 were coagulase type I, and 1 was coagulase NT. Among the 9 eta-positive and coagulase type I strains, 6 contained the mecA gene. Strains positive for sea, seb, sec, sed, seg, and tst-1 were predominantly identified in clusters II and IV. Most strains positive for an ET gene were negative for sea, seb, sec, sed, seg, and tst-1. The only exceptions were seg-positive strains identified in cluster I.
Antibiotic susceptibility profiles of eta-and etb-positive MRSA strains. Because mecA was found in a large number of the clinical isolates and in eta-and etb-positive strains in particular, we assessed the antibiotic susceptibilities of these isolates using the agar dilution method. The MRSA strains were categorized into 3 groups (eta-or etb-positive or positive for an enterotoxin gene); their antibiotic susceptibility profiles are summarized in table 2. The eta-positive MRSA strains showed borderline-tomoderate resistance to various b-lactams. Furthermore, the MIC profiles of these strains revealed a very narrow MIC range for each b-lactam, suggesting that the strains show very similar susceptibility patterns for b-lactams. This was also the case in the susceptibilities to gentamicin, minocycline, and fusidic acid; most of the strains were resistant to gentamicin but susceptible to minocycline and fusidic acid. In contrast, the MICs for erythromycin and clarithromycin showed wide variations among the strains. The antibiotic susceptibility profile of etb-positive MRSA strains was similar to that of eta-positive MRSA strains. They also showed borderline-to-moderate resistance to b-lactams. The antibiotic susceptibility profile of sea-, seb-, sec-, and sed-positive MRSA strains revealed that 4 of 6 strains were highly resistant to b-lactams (MIC, . 100), which contrasted sharply with the resistance pattern of eta-and etb-positive MRSA strains to b-lactams.
Discussion
Our study indicates that there are at least 2 distinct clonal groups carrying eta and a single clonal group carrying etb among the S. aureus strains associated with bullous impetigo in Kansai district in Japan. The most dominant clonal group is composed of strains that are coagulase type III, eta-positive, and mecA-positive and that show borderline-to-moderate resistance to b-lactam antibiotics. This eta-positive MRSA clonal group is suspected to have newly emerged for the following reasons: first, ET-producing S. aureus generally has been regarded to be susceptible to b-lactams until recently [1, 13] ; second, in an epidemiological study held in 1988, there was no b-lactam-resistant strain in 61 ET-producing strains isolated from patients with SSSS and bul- 1  2  2  1  Cfpn  2  2  2  Cftm  1  1  1  3  Cfac  3  1  1  1  Amox  1  2  2  1  Oxa  2  1  3  Frpm  1  3  2  Em  2  1  3  Clm  1  1  2  2  Gm  1  3  1  1  Mino  2  1  3  FA  4  2  Enterotoxin gene  positive  Cfdn  2  1  1  1  Ctm  2  1  3  Cdtr  2  2  2  Cpdx  2  4  Cfpn  2  4  Cftm  2  4  Cfac  2  4  Amox  2  1  3  Oxa  2  2  2  Frpm  2  2  2  Em  1  1  4  Clm  2  4  Gm  3  1  2  Mino  2  2  2  FA  3  3 NOTE. Data are the no. of strains with the indicated MIC. Amox, amoxicillin; Cdtr, cefditoren; Cfac, cefaclor; Cfdn, cefdinir; Cfpn, cefcapene; Cftm, cefteram; Clm, clarithromycin; Cpdx, cefpodoxime; Ctm, cefotiam; Em, erythromycin; eta and etb, exfoliative toxin genes; FA, fusidic acid; Frpm, faropenem; Gm, gentamicin; Mino, minocycline; Oxa, oxacillin.
a MICs of various antibiotics were determined by an agar dilution procedure according to the guidelines based on those of the National Committee for Clinical Laboratory Standards [12] . The medium used was Mueller-Hinton (MH) agar. The initial suspension, prepared by diluting MH broth cultures of the study strains (incubated overnight) and made to a density of 0.5 McFarland standard, contained 10 8 cfu/mL. The inoculum was diluted in sterile saline such that final bacterial suspensions in 5 mL yielded 1 £ 10 6 cfu, was placed on MH agar plates, and was incubated for 18 h at 35 C. The MIC was defined as the lowest concentration of the antimicrobial that allowed no growth. lous impetigo in Japan [14] ; third, most of the ETA-producing strains of S. aureus in Japan belong to coagulase type V [15] , and strains belonging to coagulase type III have been isolated only rarely and never have been predominant ETA-producing strains in Japan [15, 16] ; and, finally, our laboratory stock of ETAproducing S. aureus strains, which were collected before 1992 from patients of various geographic origins, all belong to cluster I, according to PFGE analysis (data not shown). It is most likely that an mecA-positive coagulase type III S. aureus clone acquired the eta determinant by phage conversion; however, the possibility that a preexisting but minor eta-positive clone acquired mecA cannot be excluded.
All the etb-positive strains isolated in this study were grouped in a single cluster by chromosomal DNA profiling. ETB-producing S. aureus strains isolated in Japan are categorized into coagulase type I or V [15] , but isolation of ETB-producing MRSA has never been reported previously. In this study, 6 mecA-positive strains were identified in the 9 etb-positive and coagulase type I strains. This suggests that these etb-positive MRSA have emerged from preexisting etb-positive strains by acquiring mecA.
At present, resistance levels of the eta-and etb-positive MRSA strains to b-lactams are not high, compared with antibiograms of sec-and tst-1-positive MRSA strains, some of which are highly resistant to b-lactams. However, the antibiotic susceptibility profiles revealed that this clonal group already has acquired resistance to aminoglycoside and appears to be acquiring resistance to macrolide. Thus, our data pose a possibility that a multiple antibiotic-resistant and highly b-lactam-resistant MRSA clonal group causing bullous impetigo and SSSS would emerge in the future from the eta-and etb-positive MRSA clones identified in this study. Since the primary targets of this clonal group are newborns and infants, it will become a serious clinical problem if such clones pervade the community.
Our study raises the question of whether new eta-and etbpositive MRSA groups are emerging worldwide. Monitoring of the drug resistance of strains causing bullous impetigo and SSSS and establishment of an appropriate antibiotic therapy guideline for the treatment of bullous impetigo and SSSS are definitely required to control the dissemination of the emerging MRSA clonal groups.
